Listing Regulation-arkiv - Isofol Medical

Notice to attend the Annual General Meeting held on May 19, 2026 in Isofol Medical AB (publ)

GÖTEBORG, 15 april 2026 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) hereby invites the shareholders of Isofol Medical AB […]

GOTHENBURG, Sweden, 31 March 2026 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) today announces that the exercise period for

GOTHENBURG, Sweden, 13 March 2026 – Isofol Medical AB (“Isofol” or the “Company”) carried out a rights issue of units

GOTHENBURG, Sweden, 11 March 2026 – Isofol Medical AB (“Isofol” or the “Company”) announces today that the Company has received

GOTHENBURG, Sweden, March 9, 2026 – The Nomination Committee of Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) proposes re-election of

GOTHENBURG, Sweden, February 18, 2026 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), (”Isofol” or the ”Company”), announced today that

GOTHENBURG, Sweden, November 12, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), (”Isofol” or the ”Company”), announced today that

GOTHENBURG, Sweden, November 4, 2025 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), (”Isofol” or the ”Company”), announced today that

GOTHENBURG, Sweden, 4 July 2025 – Isofol Medical AB (“Isofol” or the “Company”) today announces the outcome of the Company’s

GOTHENBURG, Sweden, 17 June 2025 – The Board of Directors of Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) (”Isofol” or